Insights from ESMO Breast 2024 Annual Meeting


 

ESMO Breast 2024 Insights: "TROPION-Breast01 Additional Safety Analysis - Dato-DXd vs. Chemo in Pretreated, Inoperable/Metastatic HR+/HER2- BC"

350 views
May 20, 2024
Comments 0
Login to view comments. Click here to Login